Acute phase response in bronchiectasis and bronchus carcinoma

Area of Science:

• Clinical chemistry
• Immunology
• Pulmonology

Background:

• The acute phase response is a systemic reaction to tissue injury or inflammation.
• C-reactive protein (CRP) and serum amyloid-A protein (SAA) are key acute phase proteins.
• Assessing the acute phase response is crucial in managing various respiratory conditions.

Purpose of the Study:

• To measure the acute phase response in patients with bronchiectasis, emphysema, bronchus carcinoma, and benign lesions.
• To investigate the relationship between acute phase protein levels and disease status.
• To explore the implications of ongoing inflammation in these conditions.

Main Methods:

• Sensitive immunoradiometric assays were used for quantifying C-reactive protein (CRP) and serum amyloid-A protein (SAA).
• Patients included those with bronchiectasis, emphysema, bronchus carcinoma, and benign space-occupying lesions.
• Clinical assessment of disease remission was performed concurrently.

Main Results:

• Significant acute phase responses were detected in patients across all studied conditions.
• Elevated CRP and SAA levels were observed even in clinically remitted bronchiectasis patients.
• In bronchus carcinoma, infection-induced inflammation often overshadowed the neoplastic process in elevating acute phase proteins.

Conclusions:

• Ongoing acute phase response in seemingly remitted bronchiectasis patients may predispose them to reactive secondary amyloidosis.
• Acute phase protein measurements have limited utility in assessing tumor burden in bronchus carcinoma due to confounding infections.
• Monitoring acute phase proteins is valuable for understanding inflammatory status in respiratory diseases.